GO:0032341 aldosterone metabolic process: Steroidogenesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032341 aldosterone metabolic process describes the chemical reactions and pathways involving aldosterone, a corticosteroid hormone produced by the zona glomerulosa of the adrenal cortex that regulates salt and water balance.
• Aldosterone synthesis is primarily regulated by the renin-angiotensin-aldosterone system (RAAS), with angiotensin II as the major acute stimulus.
• Primary aldosteronism, a common cause of secondary hypertension, is frequently driven by somatic mutations in ion channels and pumps such as KCNJ5, CACNA1D, ATP1A1, and ATP2B3.
• Calcium signaling, including T-type channels like CACNA1H (CaV3.2), plays a key role in aldosterone production and is a target of ongoing research.
• Aldosterone excess is linked not only to hypertension but also to metabolic syndrome and cardiovascular injury.
• Aldosterone-producing adenomas are a major cause of primary aldosteronism and serve as important models for studying aldosterone regulation.
Description
Aldosterone is a steroid hormone synthesized in the zona glomerulosa of the adrenal cortex, where it regulates sodium and potassium balance and extracellular fluid volume. The term GO:0032341 aldosterone metabolic process encompasses the chemical reactions and pathways involving aldosterone, including its biosynthesis, modification, and degradation. Dysregulation of aldosterone production is a central feature of primary aldosteronism, a leading cause of secondary hypertension that affects a significant proportion of hypertensive patients. Understanding the molecular mechanisms of aldosterone metabolism is therefore critical for developing targeted therapies and diagnostic tools. Recent research has highlighted the role of genetic mutations in ion channels and transporters, such as KCNJ5, CACNA1D, ATP1A1, and ATP2B3, in driving excessive aldosterone production. Additionally, calcium signaling pathways, including those mediated by T-type calcium channels like CACNA1H, have emerged as key regulators of aldosterone synthesis. This article provides a comprehensive overview of the aldosterone metabolic process, its genetic basis, associated diseases, and the research methods used to study it.
aldosterone metabolic process At A Glance
| GO ID | GO:0032341 |
|---|---|
| GO term | aldosterone metabolic process |
| Ontology | biological_process |
| Synonym | aldosterone metabolism |
| Major function | Regulation of salt and water balance through aldosterone synthesis and degradation |
| Definition | The chemical reactions and pathways involving aldosterone, a corticosteroid hormone that is produced by the zona glomerulosa of the adrenal cortex and regulates salt (sodium and potassium) and water balance. |
| Related diseases | Primary aldosteronism, hypertension, metabolic syndrome |
| Key regulators | Renin-angiotensin-aldosterone system (RAAS), calcium signaling, ion channels |
What Is GO:0032341?
GO:0032341 aldosterone metabolic process is defined as the chemical reactions and pathways involving aldosterone, a corticosteroid hormone produced by the zona glomerulosa of the adrenal cortex that regulates salt (sodium and potassium) and water balance. This process includes the biosynthesis of aldosterone from cholesterol, its secretion, and its subsequent metabolism and degradation. The term is synonymous with aldosterone metabolism and is classified under the biological process ontology.
Why Is aldosterone metabolic process Important in Cell Biology?
Aldosterone metabolic process is essential for maintaining electrolyte homeostasis and blood pressure. Dysregulation of this process leads to primary aldosteronism, a common cause of secondary hypertension that is associated with increased cardiovascular morbidity and mortality. Understanding the molecular mechanisms of aldosterone production has been greatly advanced by the discovery of somatic mutations in genes such as KCNJ5, CACNA1D, ATP1A1, and ATP2B3 in aldosterone-producing adenomas. These findings have not only clarified disease pathogenesis but also opened new avenues for targeted therapies. Moreover, aldosterone excess has been linked to metabolic syndrome, inflammation, and fibrosis, underscoring the broad clinical importance of this pathway.
• Aldosterone is a key regulator of sodium and potassium balance and extracellular fluid volume.
• Primary aldosteronism is a common and underdiagnosed cause of secondary hypertension.
• Somatic mutations in ion channels and pumps are frequent in aldosterone-producing adenomas.
• Calcium signaling pathways are critical for aldosterone synthesis and are being explored as therapeutic targets.
• Aldosterone excess contributes to cardiovascular and renal damage.
• Aldosterone-producing adenomas provide valuable models for studying steroidogenesis.
• Secondary aldosteronism can occur in conditions such as heart failure and cirrhosis.
• Oxidative stress and transcription factors like EGR1 modulate aldosterone production.
What Happens During aldosterone metabolic process?
Cholesterol Uptake and Transport
In simple terms: The process starts when adrenal cells take up cholesterol, the raw material for making aldosterone.
Aldosterone biosynthesis begins with the uptake of cholesterol from circulating lipoproteins or de novo synthesis. Cholesterol is transported into the mitochondria, where the first enzymatic step occurs. This step is mediated by the steroidogenic acute regulatory protein (StAR), which facilitates cholesterol transfer across the mitochondrial membrane. The regulation of this step is critical for the acute control of aldosterone production.
Conversion of Cholesterol to Pregnenolone
In simple terms: Cholesterol is converted into pregnenolone, the first steroid intermediate.
Inside the mitochondria, cholesterol is converted to pregnenolone by the enzyme CYP11A1 (cholesterol side-chain cleavage enzyme). This reaction is the rate-limiting step in steroidogenesis and is common to all steroid hormones. In the zona glomerulosa, this step is tightly regulated by angiotensin II and potassium levels.
Sequential Hydroxylation and Oxidation Steps
In simple terms: Pregnenolone is modified through a series of enzymatic reactions to eventually become aldosterone.
Pregnenolone is converted to progesterone, then to 11-deoxycorticosterone, and finally to corticosterone by enzymes including 3β-HSD, CYP21A2, and CYP11B1. The final step is catalyzed by aldosterone synthase (CYP11B2), which converts corticosterone to aldosterone. CYP11B2 is exclusively expressed in the zona glomerulosa and is the key enzyme for aldosterone synthesis.
Regulation by Angiotensin II and Potassium
In simple terms: The body signals the adrenal gland to make more aldosterone when blood pressure drops or potassium levels rise.
The renin-angiotensin-aldosterone system (RAAS) is the primary regulator of aldosterone production. Angiotensin II, generated in response to low blood pressure or low sodium, binds to AT1 receptors on zona glomerulosa cells, stimulating calcium signaling and CYP11B2 expression. Potassium also directly stimulates aldosterone secretion by depolarizing the cell membrane and activating voltage-gated calcium channels.
Calcium Signaling and Transcriptional Control
In simple terms: Calcium acts as a messenger inside cells to turn on the genes needed for aldosterone production.
Calcium influx through T-type channels (e.g., CACNA1H) and other calcium channels activates calmodulin and calcineurin, leading to the activation of transcription factors such as NR4A1, NR4A2, and CREB. These factors upregulate the expression of CYP11B2 and other steroidogenic enzymes. Recent studies have highlighted the role of CACNA1H mutations in primary aldosteronism, underscoring the importance of calcium signaling in this process.
Aldosterone Secretion and Metabolism
In simple terms: Once made, aldosterone is released into the blood and later broken down by the liver.
Aldosterone is secreted into the circulation and acts on mineralocorticoid receptors in the kidney, colon, and other tissues to promote sodium reabsorption and potassium excretion. It is metabolized primarily in the liver, where it is reduced and conjugated for excretion. The balance between synthesis and degradation determines circulating aldosterone levels.
Key Genes Involved in GO:0032341 aldosterone metabolic process
The following genes are critically involved in aldosterone metabolic process, including enzymes, ion channels, and transcription factors.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CYP11B2 | Aldosterone synthase; catalyzes the final step of aldosterone synthesis | Key marker of aldosterone-producing cells; target for inhibitors |
| STAR | Cholesterol transport into mitochondria | Rate-limiting for steroidogenesis; regulated by ACTH and angiotensin II |
| CYP11A1 | Cholesterol side-chain cleavage enzyme | Initiates steroid hormone synthesis |
| HSD3B2 | 3β-hydroxysteroid dehydrogenase | Converts pregnenolone to progesterone |
| CYP21A2 | 21-hydroxylase | Deficiency causes congenital adrenal hyperplasia |
| CYP11B1 | 11β-hydroxylase | Produces cortisol and corticosterone |
| KCNJ5 | Potassium channel; mutations cause depolarization and aldosterone excess | Most common mutation in aldosterone-producing adenomas |
| CACNA1D | L-type calcium channel; mutations increase calcium influx | Somatic mutations in primary aldosteronism |
| CACNA1H | T-type calcium channel; regulates calcium signaling | Mutations linked to primary aldosteronism |
| ATP1A1 | Na+/K+-ATPase; mutations alter ion transport | Somatic mutations in aldosterone-producing adenomas |
| ATP2B3 | Plasma membrane calcium ATPase; mutations affect calcium handling | Somatic mutations in aldosterone-producing adenomas |
| NR4A1 | Nuclear receptor; transcription factor regulating CYP11B2 | Mediates angiotensin II signaling |
| NR4A2 | Nuclear receptor; transcription factor regulating CYP11B2 | Mediates angiotensin II signaling |
| AT1R (AGTR1) | Angiotensin II receptor type 1 | Mediates RAAS effects on aldosterone production |
| EGR1 | Early growth response 1; regulates oxidative stress and aldosterone production | Modulates aldosterone synthesis in adrenal cells |
How Is aldosterone metabolic process Regulated?
Aldosterone metabolic process is primarily regulated by the renin-angiotensin-aldosterone system (RAAS). Angiotensin II, produced in response to low blood pressure or low sodium, binds to AT1 receptors on zona glomerulosa cells, activating phospholipase C and increasing intracellular calcium. This calcium signal activates calmodulin and calcineurin, which in turn activate transcription factors such as NR4A1, NR4A2, and CREB, leading to increased expression of CYP11B2 and other steroidogenic enzymes. Potassium also directly stimulates aldosterone secretion by depolarizing the cell membrane and opening voltage-gated calcium channels. Additionally, adrenocorticotropic hormone (ACTH) can acutely stimulate aldosterone production, though its role in chronic regulation is less clear. Recent research has identified oxidative stress and transcription factor EGR1 as modulators of aldosterone production in adrenal cells and aldosterone-producing adenomas.
aldosterone metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KCNJ5 | Primary aldosteronism (aldosterone-producing adenoma) | Knock-in of KCNJ5 mutation in adrenal cell lines (e.g., HAC15) |
| CACNA1D | Primary aldosteronism | Point mutation knock-in in H295R cells |
| ATP1A1 | Primary aldosteronism | CRISPR knockout or point mutation in adrenal cells |
| CYP11B2 | Aldosterone biosynthesis | Overexpression or knockout in HAC15 cells |
| EGR1 | Oxidative stress and aldosterone production | Knockout or overexpression in adrenal cells |
Primary Aldosteronism
Primary aldosteronism is characterized by excessive aldosterone production, suppressed renin, and hypertension. It is most commonly caused by bilateral adrenal hyperplasia or aldosterone-producing adenomas. Somatic mutations in KCNJ5, CACNA1D, ATP1A1, and ATP2B3 are found in a large proportion of aldosterone-producing adenomas, leading to increased calcium signaling and CYP11B2 expression. The discovery of these mutations has revolutionized our understanding of the disease and opened new possibilities for targeted therapy.
Secondary Aldosteronism
Secondary aldosteronism occurs when aldosterone production is increased due to extra-adrenal stimuli, such as in heart failure, cirrhosis, or renal artery stenosis. In these conditions, activation of the RAAS leads to elevated angiotensin II and subsequent aldosterone secretion. This can contribute to fluid retention and electrolyte imbalances.
Metabolic Syndrome and Cardiovascular Disease
Aldosterone excess has been linked to metabolic syndrome, inflammation, and cardiovascular injury. Studies have shown that aldosterone promotes oxidative stress, fibrosis, and endothelial dysfunction, contributing to hypertension-related organ damage. Mineralocorticoid receptor antagonists are used to block these deleterious effects.
From aldosterone metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a specific mutation increase aldosterone production? | Point mutation knock-in in HAC15 or H295R cells |
| What is the role of a gene in aldosterone synthesis? | CRISPR knockout in adrenal cell lines |
| Can a gene rescue aldosterone production? | Knock-in or overexpression in knockout background |
| How does a gene affect calcium signaling? | Tagged knock-in with calcium indicator |
| What is the effect of a drug on aldosterone production? | Overexpression or knockout cells treated with drug |
| Can we screen for regulators of aldosterone? | CRISPR library screening in adrenal cells |
How to Study the aldosterone metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR-Cas9 knockout | Loss of gene function | Identify essential genes for aldosterone synthesis |
| Point mutation knock-in | Effect of specific mutation | Model somatic mutations in primary aldosteronism |
| RNA-seq | Gene expression changes | Identify transcriptional networks |
| Calcium imaging | Intracellular calcium levels | Study calcium signaling in live cells |
| LC-MS/MS | Aldosterone and steroid levels | Quantify hormone production |
| Western blot | Protein expression | Validate knockout or overexpression |
| Immunofluorescence | Protein localization | Study subcellular distribution |
| CRISPR library screening | Genome-wide gene function | Discover novel regulators of aldosterone production |
CRISPR-Cas9 Genome Editing
CRISPR-Cas9 is widely used to create knockout, point mutation, and knock-in models in adrenal cell lines such as HAC15 and H295R. These models allow researchers to study the causal role of specific genes in aldosterone production. For example, knocking out CYP11B2 abolishes aldosterone synthesis, while introducing KCNJ5 mutations recapitulates the phenotype of aldosterone-producing adenomas.
Transcriptomics and RNA-seq
RNA sequencing can quantify the expression of steroidogenic enzymes and transcription factors under different conditions. This method is useful for identifying genes co-regulated with CYP11B2 and for understanding the transcriptional network controlling aldosterone synthesis.
Calcium Imaging
Calcium imaging using fluorescent dyes or genetically encoded indicators allows real-time monitoring of calcium signaling in adrenal cells. This is particularly relevant for studying mutations in calcium channels such as CACNA1H and CACNA1D.
Steroid Profiling by Mass Spectrometry
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the gold standard for measuring aldosterone and other steroids in cell culture media and biological samples. This method provides precise quantification of aldosterone production and can be used to assess the effects of genetic manipulations.
How CRISPR Can Be Used to Study GO:0032341 aldosterone metabolic process
Knockout
CRISPR knockout is used to completely abolish the expression of a gene of interest. In the context of aldosterone metabolic process, knocking out CYP11B2 or STAR results in loss of aldosterone production, confirming their essential roles. Knockout models are also used to study the contribution of ion channels like KCNJ5 to aldosterone regulation.
Point Mutation
Point mutation knock-in allows the introduction of specific disease-associated mutations. For example, the KCNJ5 T158A mutation, commonly found in aldosterone-producing adenomas, can be knocked into adrenal cell lines to study its effects on aldosterone production and cell proliferation.
Knock-in
Knock-in of reporter genes or tags (e.g., GFP, luciferase) into the CYP11B2 locus enables real-time monitoring of aldosterone synthase expression. This approach is valuable for high-throughput screening of compounds that modulate aldosterone production.
Overexpression
Overexpression of wild-type or mutant genes is used to study gain-of-function effects. For instance, overexpressing CACNA1H mutants in adrenal cells can increase calcium influx and aldosterone production, mimicking the phenotype of primary aldosteronism.
How EDITGENE Supports aldosterone metabolic process Research
Researchers studying aldosterone metabolic process-related genes often need to determine whether a candidate gene is causally involved in aldosterone production or disease pathogenesis. This requires precise genetic manipulation, which can be achieved through CRISPR-based genome editing. EDITGENE provides a comprehensive suite of services to support such studies, from knockout and point mutation models to overexpression and library screening.
Contact EDITGENE today to design your custom CRISPR model for aldosterone metabolic process research.
Frequently Asked Questions About aldosterone metabolic process
What is GO:0032341 aldosterone metabolic process?
GO:0032341 is a Gene Ontology term for the chemical reactions and pathways involving aldosterone, a corticosteroid hormone produced by the adrenal cortex that regulates salt and water balance.
What genes are involved in aldosterone metabolic process?
Key genes include CYP11B2, STAR, CYP11A1, HSD3B2, CYP21A2, CYP11B1, KCNJ5, CACNA1D, CACNA1H, ATP1A1, ATP2B3, NR4A1, NR4A2, and EGR1.
How is aldosterone production regulated?
Aldosterone production is primarily regulated by the renin-angiotensin-aldosterone system (RAAS), with angiotensin II and potassium as major stimuli. Calcium signaling and transcription factors also play critical roles.
What diseases are associated with aldosterone metabolic process?
Dysregulation of aldosterone metabolism is associated with primary aldosteronism, secondary aldosteronism, hypertension, metabolic syndrome, and cardiovascular disease.
What is primary aldosteronism?
Primary aldosteronism is a condition of excessive aldosterone production, often caused by adrenal adenomas or hyperplasia, leading to hypertension and low potassium.
How can CRISPR be used to study aldosterone metabolic process?
CRISPR can create knockout, point mutation, and knock-in models in adrenal cell lines to study the function of specific genes in aldosterone production.
What cell lines are used to study aldosterone production?
Common cell lines include HAC15 and H295R, which are human adrenocortical carcinoma cells capable of steroidogenesis.
What is the role of CYP11B2 in aldosterone synthesis?
CYP11B2 encodes aldosterone synthase, the enzyme that catalyzes the final step of aldosterone biosynthesis.
How is aldosterone measured in research?
Aldosterone is typically measured by immunoassays or liquid chromatography-tandem mass spectrometry (LC-MS/MS) in cell culture media or blood samples.
What are the latest findings in aldosterone research?
Recent studies have identified somatic mutations in ion channels and pumps (e.g., KCNJ5, CACNA1D) in aldosterone-producing adenomas and highlighted the role of calcium signaling and oxidative stress in aldosterone regulation.
Conclusion
Aldosterone metabolic process (GO:0032341) is a critical biological pathway that regulates electrolyte balance and blood pressure. Dysregulation of this process leads to primary aldosteronism and related cardiovascular diseases. Advances in CRISPR genome editing and other molecular techniques have greatly enhanced our understanding of the genetic and signaling mechanisms controlling aldosterone production. Continued research in this field promises to uncover new therapeutic targets and improve patient outcomes.
References
- 1. Zennaro MC et al.. 2020. Pathogenesis and treatment of primary aldosteronism.. Nat Rev Endocrinol 16(10):578-589 PMID: 32724183
- 2. Te Riet L et al.. 2015. Hypertension: renin-angiotensin-aldosterone system alterations.. Circ Res 116(6):960-75 PMID: 25767283
- 3. Dinh HA et al.. 2023. Ca(V)3.2 (CACNA1H) in Primary Aldosteronism.. Handb Exp Pharmacol 279:249-262 PMID: 37311830
- 4. Fedlaoui B et al.. 2025. Modulation of Calcium Signaling on Demand to Decipher the Molecular Mechanisms of Primary Aldosteronism.. Hypertension 82(4):716-732 PMID: 39936308
- 5. Mulatero P et al.. 2006. [Role of aldosterone in the metabolic syndrome].. G Ital Nefrol 23(4):406-14 PMID: 17063441
- 6. Hellman P et al.. 2019. Aldosterone-Producing Adenomas.. Vitam Horm 109:407-431 PMID: 30678866
- 7. Corry DB et al.. 1995. Secondary aldosteronism.. Endocrinol Metab Clin North Am 24(3):511-29 PMID: 8575407
- 8. Pang Y et al.. 2025. EGR1 regulates oxidative stress and aldosterone production in adrenal cells and aldosterone-producing adenomas.. Redox Biol 80:103498 PMID: 39826326
